Sharepoint Solutions
PRODUCTS
-
When applied to plant influents, hydrogen peroxide destroys dissolved and/or total sulfide that otherwise scavenges Fe3+ added for CEPT and/or chemical phosphorus removal from wastewater. The foundational aspect of this PRI-TECH application (called PRI-CEPT) is that one lb of total sulfide theoretically consumes 3.5 lbs Fe3+ and thus represents an additional cost of $2 – 3 per lb influent sulfide.
-
Are you anticipating rapid growth, getting ready for an equity event, or coming off a legacy system? NetSuite ERP’s all-in-one cloud business management solution helps future-proof your organization, eliminate redundancies and data silos, and automate manual processes, so you’re always ready for your next business milestone.
-
Applying experience, knowledge, and insights to plan and implement regulatory strategies for successful interactions with the FDA, MHRA, EMA, and other Global Regulatory Agencies.
-
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
-
Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.
WHITE PAPERS AND CASE STUDIES
-
A Comprehensive Planning Approach For Cancer Antibody
Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase 1 protocol for an immuno-oncology antibody.
-
Biotechnology Manufacturing Program Management
Find out how a global biotechnology manufacturing company executing several interrelated projects achieved critical project objectives while adhering to schedule and financial commitments.
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
Evansville Water & Sewer Utility: 4 Tactics For Managing & Organizing Vertical Assets
EWSU, serving 65,000 customers, revamped its vertical asset tracking with POWER Engineers to enhance maintenance workflows. Here's how they optimized their processes.
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
-
Solving The Silicone Challenge In Pre-Fillable Syringes
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing
An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.
-
Accelerating Rare Disease Trials With Biometrics Services
Find out how one therapeutics company regained control over its data assets while increasing its ability to conduct comprehensive oversight and review activities across all data sources for faster decision-making and analysis time.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
Streamline Recruitment With Confidence
Transform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.
-
Decentralized Trials For Duchenne Muscular Dystrophy
Partnering with a global biotech, see how MRN was able to conduct 180+ monthly home visits to sustain trials for rare disease genetic medicine in vulnerable pediatric patients during COVID-19.
-
RNA: The Next Era In Therapeutic Development
Review the unique set of challenges for RNA production that must be considered and solved to reach their full therapeutic potential.
NEWS
-
University Partners In New Sustainable Chemicals And Materials Manufacturing Research Hub5/16/2024
The University of Liverpool is a key partner in a new £11M research hub to improve the sustainability of chemical and polymer production.
-
Biden-Harris Administration Announces $3B For Lead Pipe Replacement To Advance Safe Drinking Water As Part Of Investing In America Agenda5/2/2024
Today, May 2, the U.S. Environmental Protection Agency announced $3B from President Biden’s Investing in America agenda to help every state and territory identify and replace lead service lines, preventing exposure to lead in drinking water.
-
DEQ Awards $75,000 To Two Idaho Wastewater Systems1/3/2025
The Idaho Department of Environmental Quality (DEQ) today awarded $75,000 to two wastewater systems to help facilities evaluate system deficiencies and determine necessary upgrades.
-
Touchlight To Supply GMP dbDNA To Support University Of Nottingham's Clinical Study For A Next-Generation Vaccine For Zika Virus8/21/2024
Touchlight, an innovation-driven contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, is proud to announce the clinical supply of its proprietary dbDNA to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
-
Biden-Harris Administration Announces $7.5B In Available Financing For Water Infrastructure Projects9/6/2024
Today, September 6, the U.S. Environmental Protection Agency announced the availability of $7.5B of Water Infrastructure Finance and Innovation Act (WIFIA) funding.